CheckMan Stock Market Overview
Trending Stocks
Red List
In Today's Headlines
Bank of America Corporation (BAC) Presents at Morgan Stanley US Financials Conference 2026 Transcript
Oil-Dri Corporation of America (ODC) Q3 2026 Earnings Call Transcript
AMRX is expanding into GLP-1 manufacturing and biosimilars, using partnerships and acquisitions to strengthen its higher-value product strategy.
RGTI advances its quantum roadmap with a 108-qubit Cepheus system, rising customer adoption and a target of quantum advantage within three years.
VEEV's Falcon and Vault AI deepen workflow automation across life sciences, while management expects AI revenues to remain immaterial in fiscal 2027.
Samsara Inc. (IOT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Concrete Pumping (BBCP) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Dycom Industries (DY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
The EU on Tuesday rejected Apple's blame for the delayed rollout of its AI-enhanced voice assistant, saying it was up to the U.S. giant to make products that follow the rules.
NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ADC Therapeutics SA (“ADC” or the “Company”) (NYSE: ADCT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.